Nuvectis Pharma Inc.

6.45
-0.24 (-3.59%)
At close: Mar 03, 2025, 11:36 AM

Nuvectis Pharma Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 18.53M 19.13M 19.99M 5.74M n/a
Short-Term Investments n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets n/a n/a n/a 824K n/a
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 74K 59K 412K 91K n/a
Total Current Assets 18.61M 19.18M 20.41M 5.83M n/a
Property-Plant & Equipment n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets n/a n/a n/a 824K n/a
Total Assets 18.61M 19.18M 20.41M 6.66M n/a
Account Payables 2.5M 2.77M 2.91M 1.06M 10K
Deferred Revenue n/a n/a n/a n/a n/a
Short-Term Debt n/a n/a n/a n/a n/a
Other Current Liabilities 6.4M 4.21M 3.28M 1.36M n/a
Total Current Liabilities 8.89M 6.98M 6.19M 2.42M 10K
Long-Term Debt n/a n/a n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a
Total Long-Term Liabilities n/a n/a 2.91M 15.25M n/a
Total Liabilities 8.89M 6.98M 6.19M 17.66M 10K
Total Debt n/a n/a n/a n/a n/a
Common Stock n/a n/a 14.75B n/a n/a
Retained Earnings -73.25M -54.24M -31.98M -12.9M -10K
Comprehensive Income n/a n/a -14.75B 0.00 n/a
Shareholders Equity 9.71M 12.2M 14.22M -11.01M -10K
Total Investments n/a n/a n/a n/a n/a